Sensei Biotherapeutics (SNSE) Institutional Ownership $8.68 +1.18 (+15.73%) Closing price 08/15/2025 03:58 PM EasternExtended Trading$8.03 -0.65 (-7.49%) As of 08/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sensei Biotherapeutics (NASDAQ:SNSE)CurrentInstitutional OwnershipPercentage10.50%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$905.55KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$576.08K Get SNSE Insider Trade Alerts Want to know when executives and insiders are buying or selling Sensei Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNSE Institutional Buying and Selling by Quarter Sensei Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 XTX Topco Ltd62,903$31K0.0%+351.7%0.250% 2/13/2025 Renaissance Technologies LLC156,800$77K0.0%-27.3%0.623% 11/15/2024 National Bank of Canada FI45,575$27K0.0%+355.8%0.181% 11/14/2023 Newtyn Management LLC1,800,000$1.35M0.3%-1.5%7.200% 11/14/2022 RA Capital Management L.P.683,529$1.06M0.0%-5.5%2.225% 7/22/2022 Truist Financial Corp19,934$45K0.0%-60.5%0.065% 5/3/2022Leo Brokerage LLC14,845$34K0.0%N/A0.048% 11/16/2021 Millennium Management LLC258,659$2.72M0.0%N/A0.846% 11/16/2021 Moore Capital Management LP49,341$519K0.0%-61.3%0.161% 11/12/2021 Tao Capital Management LP32,784$345K0.1%N/A0.107% Get the Latest News and Ratings for SNSE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sensei Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021 The Manufacturers Life Insurance Company13,478$142K0.0%N/A0.044% 11/12/2021 Geode Capital Management LLC273,978$2.88M0.0%+93.2%0.896% 11/10/2021 Citigroup Inc.2,409$25K0.0%+565.5%0.008% 11/9/2021BlackRock Inc.1,000,322$10.52M0.0%+175.2%3.270% 11/5/2021 Truist Financial Corp70,374$740K0.0%N/A0.230% 11/4/2021 Deutsche Bank AG12,021$126K0.0%+158.3%0.039% 11/1/2021 SG Americas Securities LLC12,614$133K0.0%N/A0.041% 10/13/2021BFT Financial Group LLC14,845$156K0.0%N/A0.049% 8/17/2021 Citadel Advisors LLC283,667$2.77M0.0%-59.0%0.927% 8/16/2021 Alyeska Investment Group L.P.40,000$390K0.0%N/A0.131% 8/16/2021 Tudor Investment Corp Et Al28,111$274K0.0%-75.2%0.092% 8/16/2021 Charles Schwab Investment Management Inc.54,965$537K0.0%+18.9%0.180% 8/16/2021 State Street Corp100,000$976K0.0%+70.2%0.327% 8/13/2021 Formula Growth Ltd.100,000$976K0.1%+77.7%0.327% 8/13/2021 Northern Trust Corp75,011$733K0.0%-8.5%0.245% 8/13/2021 Geode Capital Management LLC141,809$1.38M0.0%+20.8%0.464% 8/13/2021 Vanguard Group Inc.387,753$3.78M0.0%+19.4%1.268% 8/12/2021 JPMorgan Chase & Co.179,078$1.75M0.0%+15.1%0.585% 8/11/2021 Bank of New York Mellon Corp18,431$180K0.0%+31.1%0.060% 8/11/2021BlackRock Inc.363,466$3.55M0.0%+9.2%1.188% 8/11/2021 Deutsche Bank AG4,653$45K0.0%-73.3%0.015% 8/2/2021 New York State Common Retirement Fund5,396$53K0.0%+37.2%0.018% (Data available from 1/1/2016 forward) SNSE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNSE shares? During the previous two years, the following institutional investors and hedge funds held shares of Sensei Biotherapeutics shares: Newtyn Management LLC ($1.35M), Renaissance Technologies LLC ($77K), and XTX Topco Ltd ($31K), National Bank of Canada FI ($27K).Learn more on Sensei Biotherapeutics' institutional investors. What percentage of Sensei Biotherapeutics' stock is owned by institutional investors? 10.50% of Sensei Biotherapeutics' stock is owned by institutional investors. Learn more on SNSE's institutional investor holdings. Which institutional investors have been buying Sensei Biotherapeutics' stock? The following institutional investors have purchased Sensei Biotherapeutics' stock in the last 24 months: XTX Topco Ltd ($48.98K), and National Bank of Canada FI ($35.58K). How much institutional buying is happening at Sensei Biotherapeutics? Institutional investors have bought a total of 84,552 shares in the last 24 months. This purchase volume represents approximately $905.55K in transactions. Which of Sensei Biotherapeutics' major shareholders have been selling company stock? The following institutional investors have sold Sensei Biotherapeutics stock in the last 24 months: Renaissance Technologies LLC ($58.77K). How much institutional selling is happening at Sensei Biotherapeutics? Institutional investors have sold a total of 58,772 shares in the last 24 months. This volume of shares sold represents approximately $576.08K in transactions. Related Companies CALC Major Shareholders PLUR Major Shareholders JSPR Major Shareholders OVID Major Shareholders STTK Major Shareholders ALXO Major Shareholders FGEN Major Shareholders PEPG Major Shareholders XLO Major Shareholders KPTI Major Shareholders This page (NASDAQ:SNSE) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access